Elevated serum soluble Fas ligand in natural killer cell proliferative disorders

British Journal of Haematology

Volumn 103, Issue 4, 1998, Pages 1164-1166

  Kato, Kei ^a   Ohshima, Koichi ^a   Ishihara, Shigehiko ^b   Anzai, Keizo ^a   Suzumiya, Junji ^a   Kikuchi, Masahiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Kashiwara Municipal Hosp   (Japan)

Author keywords

EBV; Mosquito bite hypersensitivity; NK leukaemia; NK lymphoma; sFasL

Indexed keywords

FAS LIGAND; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; LEUKEMIA; LYMPHOMA; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REMISSION; SCHOOL CHILD;

ADOLESCENT; ADULT; ANIMALS; CULICIDAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; HUMANS; HYPERSENSITIVITY; INSECT BITES AND STINGS; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED;

EID: 0032441141     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01095.x     Document Type: Article

References (12)

1. Arase, U., Arase, N. & Saito, T. (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells. Journal of Experimental Medicine, 181, 1235-1238.
2. Imamura, N., Kusunoki, Y., Kawa-Ha, K., Yumura, K., Hara, J., Oda, K., Abe, K., Dohy, H., Inada, T., Kajihara, H. & Kuramoto, A. (1990) Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. British Journal of Haematology, 75, 49-59.
3. Ishihara, S., Ohshima, K., Tokura, Y., Yabuta, R., Imaishi, H., Wakiguchi, H., Kurashige, T., Kishimoto, H., Katayama, I., Okada, S. & Kawa-Ha, K. (1997) Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Japanese Journal of Cancer Research, 88, 82-87.
4. Jaffe, E.S., Chan, J.K., Su, I.J., Frizzera, G., Mori, S., Feller, A.C. & Ho, F.C. (1996) Report of the workshop on nasal and related extranodal angiocentric T/natural killer-cell lymphoma: definitions, differential diagnosis, and epidemiology. American Journal of Surgical Pathology, 20, 103-111.
5. Kawa-Ha, K., Ishihara, S., Ninomiya, T., Yumura-Yagi, K., Hara, J., Murayama, F., Tawa, A. & Hirai, K. (1989) CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. Journal of Clinical Investigation, 84, 51-55.
6. Ogasawara, J., Watanebe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T. & Nagata, S. (1993) Lethal effect of the anti-Fas antibody in mice. Nature, 364, 806-809.
7. Sato, K., Kimura, F., Nakamura, Y., Murakami, H., Yoshida, M., Tanaka, M., Nagata, S., Kanatani, Y., Wakimoto, N., Nagata, N. & Motoyoshi, K. (1996) An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand. British Journal of Haematology, 94, 379-382.
8. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. & Nagata, S. (1995) Expression of the Fas ligand in cells of T cell lineage. Journal of Immunology, 154, 3806-3813.
9. Suda, T., Takahashi, T., Golstein, P. & Nagata, S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell, 75, 1169-1178.
10. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A.H. & Nagata, S. (1996) Fas ligand in human serum. Nature Medicine, 2, 317-322.
11. Tanaka, M., Suda, T. Takahashi, T. & Nagata, S. (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO Journal, 14, 1129-1135.
12. Tokura, Y., Tamura, Y., Takigawa, M., Koida, M., Satoh, T., Sakamoto, T., Horiguchi, D. & Yamada, M. (1990) Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Archives of Dermatology, 126, 362-368.